News & Events about Agios Pharmaceuticals Inc.
Agios Pharmaceuticals (NASDAQ:AGIO Get Rating) and Aileron Therapeutics (NASDAQ:ALRN Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, ...
Totus Medicines Expands its Scientific Advisory Board with the Addition of Dr. Lewis Cantley, Dr. Hope Rugo, and Dr. Josep Tabernero Totus Medicines Expands its Scientific Advisory Board with the Addition of Dr. Lewis Cantley, Dr. Hope Rugo, and Dr. Josep Tabernero PR Newswire EMERYVILLE, Calif...
InvestorPlace
2 months ago
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio.
The post 7 Biotech Stocks to Buy for 100% Returns appeared first on InvestorPlace...
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO Get Rating) Director David P. Schenkein sold 20,000 shares of Agios Pharmaceuticals stock in a transaction that occurred on Monday, March 27th. The shares were sold at an average price of $22.15, for a total transaction of $443,000.00. Following the ...
StockNews.com lowered shares of Agios Pharmaceuticals (NASDAQ:AGIO Get Rating) from a hold rating to a sell rating in a research report sent to investors on Friday. Several other research firms also recently issued reports on AGIO. Piper Jaffray Companies assumed coverage on Agios Pharmaceuticals in...